Kyriazi Theo Melas - Jun 8, 2023 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Director
Signature
/s/ Marella Thorell, Attorney-in-Fact for Theodose Melas-Kyriazi
Stock symbol
EVLO
Transactions as of
Jun 8, 2023
Transactions value $
$0
Form type
4
Date filed
6/12/2023, 04:04 PM
Previous filing
Feb 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +20K $0.00 20K Jun 8, 2023 Common Stock 20K $0.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant.

Remarks:

Exhibit 24: Power of Attorney